Health Condition 1: K80- Cholelithiasis
Conditions
Interventions
Intervention1: Lignocaine and Ketamine: lignocaine (loading dose with 2 mg/kg followed by 1.5 mg/kg/hr continuous infusion) and a single dose of ketamine 0.4 mg/kg given 5 minutes before estimated ext
Sponsors
Dr Haneefa Khan
Eligibility
Inclusion criteria
Inclusion criteria: 1) The patients who have given informed consent. 2) The Patients of ASA-American Society of Anaesthesiologists Grade I, II. 3) The Patients aged 18 -50yrs. 4) The patients who are electively scheduled for laproscopic cholecystectomy.
Exclusion criteria
Exclusion criteria: 1) The patients who refused to participate in the study. 2) The patients with ASA Grade 3 and above. 3) Patients aged below 18 and above 50 years. 4) Vestibular disorders, pregnancy and patients with history of chemotherapy. 5) The patients with known hypersensitivity to the local anaesthetics & Opioids.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduced incidence of PONV(post operative nausea & vomiting) in laproscopic cholecystectomy patients without compromising on intraoperative haemodynamic stability of patient. Timepoint: 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Prevention Of Opioid Related Adverse Effects Timepoint: 24 hours;Early Recovery After Surgery Timepoint: 24 hours;Patients Comfort During Perioperative Period Timepoint: 24 hours;Patients Satisfaction During Perioperative Period. Timepoint: 24 hours | — |
Countries
India
Contacts
Public ContactDr Avijit Banerjee
Peerless Hospital & B K Roy Research Centre
Outcome results
None listed